ACTRN12609000655246尚未招募4 期
se of aldosterone blockade to improve cardiac function in obesity
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Obesity: Body mass index (BMI) > 30
排除标准
- •Diabetes, cardiovascular disease or other chronic disease
研究者
相似试验
招募中
3 期
Evaluation of spironolactone on heart related mortality and morbidity among patients undergoing chronic kidney dialysisCTRI/2019/06/019703Population Health Research Institute
进行中（未招募）
1 期
Effects of Spironolactone in Heart Failure with Preserved Ejection Fraction: Measured by CMR, Echo, Excercise Capacity and Quality of Life QuestionaireEUCTR2013-000867-10-GBniversity of Leeds51
已完成
3 期
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular DystrophyDuchenne Muscular DystrophyNCT02354352Ohio State University52
已完成
不适用
Does aldosterone blockade improve endothelial dysfunction in patients with coronary artery disease but without heart failure?Coronary artery diseaseCirculatory SystemISRCTN70010120niversity of Dundee (UK)88
已完成
3 期
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic FunctionCardiovascular DiseasesHeart DiseasesHeart Failure, CongestiveNCT00094302Carelon Research3,445